This grant application seeks to renew funding for an ongoing project designed to elucidate the mechanisms that underlie multiple functions of the glycoprotein (GP) Ib-IX-V receptor complex, specifically as they relate to the interaction with its main ligands, thrombin and von Willebrand factor (VWF). We propose to integrate structural information, ex vivo mutagenesis of specific protein domains and in vivo modification of cell expressed GPIb1 to establish how 1-thrombin binds to this receptor, how the interaction affects thrombin- mediated procoagulant and anticoagulant pathways, and the relationship with the binding of the VWF A1 domain (VWF-A1). These studies will demonstrate that GPIb is a key modulator of thrombin function during the response to vascular injury, and will highlight in this context a novel prothrombotic role of thrombin, independent of proteolytic activity and coordinated through concurrent interactions with VWF-A1 and GPIb. We will establish the structural determinants of this trimolecular assembly, investigate how it affects VWF and thrombin-initiated GPIb signaling, and demonstrate the consequent in vivo relevance in the arterial as well as venous circulation during thrombogenesis induced by different models of vascular lesion. We will also develop recent unexpected evidence firmly indicating that mice deficient in GPIb-IX-V function are protected from death in an endotoxin endotoxin-induced model of inflammation, indicating a potentially far-reaching new mechanism that involves GPIb in the regulation of innate immune responses. Altogether, these studies will advance our knowledge of the structural and functional biology of GPIb-IX-V, a key receptor expressed on platelets and, as hypothesized here, on cells of the innate immune system. The new findings resulting from the proposed research will have a significant impact on the understanding, diagnosis and treatment of thromboembolic and inflammatory diseases relevant to human health. 1

Public Health Relevance

Glycoprotein Ib is a major protein of the platelet surface and binds several components of the coagulation system, including thrombin, and adhesive proteins, including von Willebrand factor. These interactions are important for the biological mechanisms that protect from bleeding, but in arteries with atherosclerosis can become a major cause of vascular occlusions that lead to serious consequences such as myocardial infarction and stroke. The studies we propose are aimed at improving our understanding of the mechanisms responsible for these processes. We have also discovered that glycoprotein Ib is important in regulating inflammatory responses, a new finding that adds to the role of this receptor in defending the organism from illness. This new knowledge may translate into improved diagnosis and treatment of common and serious diseases, thus enhancing human health.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL042846-24
Application #
8386990
Study Section
Special Emphasis Panel (ZRG1-VH-G (02))
Program Officer
Link, Rebecca P
Project Start
1996-09-01
Project End
2014-11-30
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
24
Fiscal Year
2013
Total Cost
$447,442
Indirect Cost
$211,822
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Guidotti, Luca G; Inverso, Donato; Sironi, Laura et al. (2015) Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell 161:486-500
Shim, Chi Young; Liu, Ya Ni; Atkinson, Tamara et al. (2015) Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis. Circ Cardiovasc Imaging 8:e002765
Kaplan, Zane S; Zarpellon, Alessandro; Alwis, Imala et al. (2015) Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4. Nat Commun 6:7835
Baccala, Roberto; Welch, Megan J; Gonzalez-Quintial, Rosana et al. (2014) Type I interferon is a therapeutic target for virus-induced lethal vascular damage. Proc Natl Acad Sci U S A 111:8925-30
Yokota, N; Zarpellon, A; Chakrabarty, S et al. (2014) Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice. J Thromb Haemost 12:71-81
Liu, Yani; Davidson, Brian P; Yue, Qi et al. (2013) Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. Circ Cardiovasc Imaging 6:74-82
Habart, David; Cheli, Yann; Nugent, Diane J et al. (2013) Conditional knockout of integrin α2β1 in murine megakaryocytes leads to reduced mean platelet volume. PLoS One 8:e55094
Khanicheh, Elham; Qi, Yue; Xie, Aris et al. (2013) Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties. Arterioscler Thromb Vasc Biol 33:2187-92
Scheppke, Lea; Murphy, Eric A; Zarpellon, Alessandro et al. (2012) Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood 119:2149-58
Doshi, Nishit; Orje, Jennifer N; Molins, Blanca et al. (2012) Platelet mimetic particles for targeting thrombi in flowing blood. Adv Mater 24:3864-9

Showing the most recent 10 out of 86 publications